SSRIs vs. TCAs in the treatment of panic disorder: a meta‐analysis

  title={SSRIs vs. TCAs in the treatment of panic disorder: a meta‐analysis},
  author={Abraham Bakker and Anton J. L. M. Van Balkom and Philip Spinhoven},
  journal={Acta Psychiatrica Scandinavica},
Bakker A, van Balkom AJLM, Spinhoven P. SSRIs vs. TCAs in the treatment of panic disorder: a meta‐analysis. Acta Psychiatr Scand 2002: 106: 163–167. © Blackwell Munksgaard 2002. 
Pharmacological treatment of panic disorder
This discovery was instrumental in the subsequent delineation and nosological differentiation of panic disorder from the old concept of anxiety neurosis, and ushered the treatment of the condition into the modern era of psychopharmacology.
Slow vs standard up‐titration of paroxetine in the treatment of panic disorder: A prospective randomized trial
Patients with panic disorder might be sensitive to the stimulating effects of selective serotonin reuptake inhibitors (SSRI), thus requiring low dosages at treatment initiation, so eventual differences in terms of effectiveness and tolerability between a slow up‐titration with paroxetine and a standard one are assessed.
Spontaneous treatment discontinuation in panic disorder patients treated with antidepressants
The relationships between long‐term treatment response, side‐effects and drug discontinuation in panic disorder (PD)–agoraphobia are examined.
Antidepressants, benzodiazepines and azapirones for panic disorder in adults: a network meta-analysis
This is a protocol for a Cochrane Review (Intervention) to compare individual active drugs and placebo in terms of efficacy and acceptance in the acute treatment of panic disorder, with or without agoraphobia.
Panic! Its Prevalence, Diagnosis and Treatment via the Internet
As evidenced by several trials, cognitive behavior therapy (CBT) is a highly effective treatment for Panic disorder with or without agoraphobia (PD). However, therapists are short in supply, and pa
Brief cognitive‐behavioral therapy for panic disorder has the potential to lower health care costs and enhance dissemination of evidence‐based interventions to clinical practice. This manuscript
The assessment and treatment of panic disorder in general practice
An overview of PD in general practice is provided and a guideline for case identification and therapeutic options is included to help general practitioners better understand this condition.
Empirically supported treatments for panic disorder.
A Naturalistic Long-Term Comparison Study of Selective Serotonin Reuptake Inhibitors in the Treatment of Panic Disorder
Most of PD patients responded well to 12-month treatment with either citalopram, fluoxetine, fluvoxamine, or paroxetines, and the overall response rate was equal after the first 4 weeks of treatment.
Pharmacotherapy and psychotherapy for panic disorder
Cognitive-behavioral therapy (CBT) is most evidently the psychotherapy of choice for panic disorder, and can result in the maintenance of long-term improvements.


Treatment of panic disorder with imipramine alone.
Ten patients with panic disorder treated solely with imipramine reported cessation of panic attacks and considerable overall improvement in an open pilot trial.
Nortriptyline in the treatment of panic disorder and agoraphobia with panic attacks.
Thirty-four consecutive patients with panic disorder or agoraphobia with panic attacks were treated with nortriptyline at the LAC-USC Medical Center's Anxiety Disorders Clinic. Fourteen (67%) of the
Effect of a serotonin and noradrenaline uptake inhibitor in panic disorder: A double-blind comparative study with fluvoxamine and maprotiline.
A double-blind comparative study with fluvoxamine and maprotiline, a specific serotonin uptake inhibitor, was conducted in 44 patients suffering from panic disorder with or without phobic avoidance.
Serotonin, Panic Disorder and Agoraphobia: Short‐term and Long‐term Efficacy of Citalopram in Panic Disorders
The hypothesis that serotonin reuptake inhibition is essential for the antipanic effect of antidepressants as well as for the initial paradoxical increase of anxiety often seen with these drugs is supported.
Sertraline in the treatment of panic disorder: a flexible-dose multicenter trial.
Results support the safety and efficacy of sertraline for the short-term treatment of patients with panic disorder.
Fluoxetine in panic disorder.
Twenty-five patients with a primary DSM-III-R diagnosis of panic disorder with or without agoraphobia were treated openly with the serotonin uptake inhibitor fluoxetine for up to 12 months, andeteen experienced moderate to marked improvement in panic attacks.
Clinical evaluation of alprazolam in patients with panic disorder: A double‐blind comparison with imipramine
The antipanic effect and tolerability of alprazolam and imipramine were compared during 9 weeks in 55 inpatients with panic disorder with or without agoraphobia. Both drugs decreased significantly
Clomipramine treatment of panic disorder: pros and cons.
Patients with DSM-III-R panic disorder with or without agoraphobia with clomipramine should not be used as a first-line antipanic medication.
Moclobemide for anxiety disorders
Moclobemide is a reversible selective inhibitor of monoamine oxidase A. It has proven efficacy in a wide range of depressive disorders, including agitated anxious depression. In an international,